AUSTRALIAN DRUG DEVELOPMENT BLOG
The Latest Blogs from Agilex Biolabs
![](https://www.agilexbiolabs.com/wp-content/uploads/2024/06/AGX_thumb_2024-06a_3decades-small-mol.jpg)
Author By Jeremy BurtPosted on
Agilex has offered our clients small molecule solutions that lead to their success. Agilex Biolabs is celebrating its 29th year...
![](https://www.agilexbiolabs.com/wp-content/uploads/2024/05/AGX_thumb_CNS-neurodegeneration.jpg)
Author By Jeremy BurtPosted on
For 3 decades, Agilex has supported biotech companies with CNS-targeted medicines. For almost 3 decades, Agilex Biolabs has sup...
![](https://www.agilexbiolabs.com/wp-content/uploads/2024/05/AGX_thumb_WRIB-Poster-2024.jpg)
Author By Jeremy BurtPosted on
Let's face it – we are an aging population throughout the world. More and more, we are seeing these neurological disorders growi...
![](https://www.agilexbiolabs.com/wp-content/uploads/2024/05/AGX_thumb_Small-Mol-Cannabis.jpg)
Author By Jeremy BurtPosted on
In molecular biology and pharmacology, small molecules are noted for their ability to quickly modulate their actions. This is beca...
![Small Molecule Support for Psychedelics Research Projects](https://www.agilexbiolabs.com/wp-content/uploads/2024/03/AGX_thumb_2023-03B_Small-Mol-Psychedlics.jpg)
Author By Jeremy BurtPosted on
Applying Decades of Experience with an Eye on the Future of Small Molecule Development For decades before antibody drugs were d...
![Inflammatory Skin Disorders](https://www.agilexbiolabs.com/wp-content/uploads/2024/03/AGX_thumb_2023-03A_Atopic-Dermatitis.jpg)
Author By Jeremy BurtPosted on
Looking beyond the surface on the Complexity of Atopic Dermatitis Addressing inflammatory skin disorders like atopic dermatitis...
![Video Interview with Jason Valentine](https://www.agilexbiolabs.com/wp-content/uploads/2024/03/AGX_thumb_2024-01D_Meet-the-Team-Jason-Valentine-1.jpg)
Author By Jeremy BurtPosted on
We took some time to sit down and talk with Jason so you could get to know him a bit better... My name is Jason Valentine. I'm...
![Video Interview with Cameron Smith](https://www.agilexbiolabs.com/wp-content/uploads/2024/03/AGX_thumb_2024-Videos_Meet-the-Team_Cameron-1.jpg)
Author By Jeremy BurtPosted on
We took some time to sit down and talk with Cameron so you could get to know him a bit better... My name is Cameron Smith. I'm...
![Video Interview with Kurt Sales, PhD](https://www.agilexbiolabs.com/wp-content/uploads/2024/03/AGX_thumb_2024-01D_Meet-the-Team-Kurt-Sales-1.jpg)
Author By Jeremy BurtPosted on
We took some time to sit down and talk with Dr Sales so you could get to know him a bit better... My name is Kurt Sales. I’m...
![Unraveling the Untapped Potential of Immuno-Oncology Technology](https://www.agilexbiolabs.com/wp-content/uploads/2024/03/AGX_thumb_2024-02B_Cancer-Treatments-of-Tomorrow.jpg)
Author By Jeremy BurtPosted on
Unraveling the Untapped Potential of Immuno-Oncology Technology Both the pace and varied methods by which medical clinicians ut...
![](https://www.agilexbiolabs.com/wp-content/uploads/2024/02/AGX_thumb_2023-02C_Receptor-Occupancy.jpg)
Author By Jeremy BurtPosted on
A Quick Look at Agilex Biolabs' Expertise and Capabilities In the intricate landscape of drug discovery and development, the as...
![](https://www.agilexbiolabs.com/wp-content/uploads/2024/01/AGX_thumb_2024-01C_Evolution-PK-Small-Mol.jpg)
Author By Jeremy BurtPosted on
Agilex Biolabs has extensive knowledge on small molecule development and pharmacokinetic services. Today, pharmacokinetics (PK)...